No description available.

Methyl-CpG binding protein 2 (MeCP2) and histone H1 are important chromatin associated proteins. Both exhibit their own extent of complexity as MeCP2 is an intrinsically disordered protein (IDP) that interacts with many different partners involved in several cellular processes and histone H1 consists of 11 different subtypes each of them associated with different posttranslational modifications (PTMs). An interesting avenue for the study of these proteins is in neurons where MeCP2 is very abundant and histone H1 level is half that observed in other somatic tissues. Several reports in the past have proposed that this lower level of histone H1 is due to the abundance of MeCP2 which displaces histone H1. However, this hypothesis has been debated and there is no clear consensus. In an attempt to study this controversy, a cell model system ReNCell WT and MeCP2-KO was used that can be induced to differentiate into neurons. The protein levels, transcript levels and localization of histone H1 subtypes in these cells were analyzed using HPLC, RT-qPCR and immunofluorescence, respectively. The results show that ReNCell WT and MeCP2-KO do not exhibit significant differences in their relative amount of histone H1 protein and transcript level neither at the proliferative nor at the later differentiated stages. However, HPLC analyses show that the histone H1 subtypes of these two cell types exhibit significant elution differences probably resulting from differences in their PTM content. Immunofluorescence analyses show that WT ReNCell differentiation as determined by extension of dendritic or axonic processes can be seen to occur over the course of one week and there is a significant difference in the nuclear area of these two cells at 8 DIV. This study provides important preliminary data for future research in MeCP2 and histone H1 using this cell model system and show that MeCP2 may have a bearing on histone H1 PTMs. / Graduate

Le génome eucaryote est contenu dans le noyau sous forme de chromatine, le nucléosome étant son unité de base. Le nucléosome est composé d'ADN enroulé autour d'un octamère d'histones. La chromatine permet l'empaquetage de l'ADN, mais module également diverses fonctions cellulaires telles que la transcription, la réplication et la réparation de l'ADN. Il existe différents types de dommages à l'ADN, les plus toxiques étant les cassures d'ADN double brins (DNA double-strand breaks, DSBs) qui si elles ne sont pas réparées, peuvent compromettre l'intégrité du génome. Les histones peuvent être l'objet de modifications post-traductionnelles qui sont essentielles pour réguler la chromatine. NuA4 est un complexe acétyltransférase qui a été bien décrit pour son rôle dans la transcription et la réparation de l'ADN. Au fil des années, diverses études ont montré que NuA4 acétyle les histones, cependant, de nouvelles études ont permis de mettre en évidence des cibles non-histones. Des précédentes études du laboratoire ont montrées comment NuA4 est recruté au site de dommages à l'ADN et comment il régule la réparation de l'ADN en acétylant les histones et les protéines de réparation. Dans ce travail, nous disséquons davantage le rôle de NuA4 dans la réparation des dommages à l'ADN. Ainsi, nous avons pu déterminer qu'il peut être recruté aux DSBs par un mécanisme alternatif reposant sur la protéine Lcd1ᴬᵀᴿᴵᴾ, indépendamment de Xrs2. Nous décrivons également deux nouvelles cibles acétylées par NuA4, Nej1 et Yku80, deux facteurs qui sont impliqués dans la réparation par jonctions d'extrémités non-homologue (non-homologous end-joining, NHEJ). De plus, nous avons établis qu'il existe une relation antagoniste entre NuA4 et les facteurs du NHEJ. L'acétylation de certains de ces facteurs favorise la réparation des DSBs par des voies de réparation qui reposent sur la résection des extrémités de la cassure. Cette régulation semble conservée au cours de l'évolution puisque le complexe mammifère TIP60 antagonise 53BP1 (levure Rad9) qui favorise la réparation par NHEJ et ainsi permet de réguler le choix de la voie de réparation. De plus, nous démontrons, que chez la levure, la queue N-terminale de l'histone H2A contient un site SQ qui est phosphorylé par Mec1ᴬᵀᴿ en présence de dommages à l'ADN. Nos données suggèrent que cette marque d'histone est nécessaire pour maintenir la fidélité de la résection de l'extrémité de l'ADN en modulant la liaison de Rad9⁵³ᴮᴾ¹. Nous supposons que cette phosphorylation agit de façon similaire à l'ubiquitination sur H2A chez les mammifères, mettant en évidence que des modifications d'histones différentes chez plusieurs organismes convergent pour effectuer une même fonction. Enfin, nous décrivons le rôle du domaine YEATS de la sous-unité Yaf9 partagée par les complexes SWR1 et NuA4. Nous montrons que ce domaine reconnaît la modification d'histone H3K27ac et est impliqué dans l'échange d'histone Htz1ᴴ²ᴬ·ᶻ. Ainsi cette modification est impliquée dans la régulation de la transcription et de la réparation des dommages à l'ADN. Dans l'ensemble, les résultats présentés dans cette thèse ajoutent des contributions importantes aux connaissances actuelles qui permettront de mieux comprendre le rôle de NuA4 et des modifications d'histones dans la réparation des dommages à l'ADN et dans le maintien de l'intégrité du génome. / The eukaryotic genome is packed in the nucleus in the form of chromatin, with the nucleosome being its basic unit. The nucleosome is composed of DNA wrapped around an octamer of histone proteins. Chromatin not only helps in the packing of DNA but also modulates various cellular functions such as transcription, replication and DNA repair. DNA damage manifests in various forms with DNA double-strand breaks (DSBs) being the most toxic which, if unrepaired, compromises genome integrity. Histones are decorated by various post-translational modifications that are essential for fine-tuning and regulation of chromatin. NuA4 is an acetyltransferase complex which has been well described for its role in transcription and DNA repair. Over the years, various studies have shown that NuA4 acts through acetylation of histones, however, new studies have highlighted non-histone targets. Our previous studies have shown how NuA4 is recruited to the site of DNA damage and how it regulates DNA repair by acetylating histones and repair proteins. Here we further dissect the role of NuA4 in DNA repair and found that it can be recruited to DSBs by an alternative mechanism relying on Lcd1ᴬᵀᴿᴵᴾ, independently of Xrs2. We also describe two new targets of NuA4 acetyltransferase activity, Nej1 and Yku80, both factors involved in repair by non-homologous end-joining (NHEJ). In fact, we observe an antagonistic relationship between NuA4 and NHEJ factors, with acetylation of the latter favouring repair of DSBs by resection-based pathways. This regulation seems evolutionary conserved with the mammalian TIP60complex antagonising pro-NHEJ factor 53BP1 (yeast Rad9) to govern the choice of repair pathway. In line with this, we further show that yeast histone H2A N-terminal tail harbours an SQ-site which is phosphorylated by Mec1ᴬᵀᴿ upon DNA damage. Our data suggests this histone mark is required to maintain the fidelity of DNA end resection by modulating the binding of Rad9⁵³ᴮᴾ¹. We speculate that this phosphorylation acts similarly to ubiquitination of mammalian H2A tail, highlighting different histone modifications across organisms converging to achieve a similar function. Lastly, we describe the role of the YEATS domain found in the Yaf9 subunit shared by SWR1 and NuA4 complexes. We show that this domain recognizes H3K27ac and is involved in histone Htz1ᴴ²ᴬ·ᶻ exchange, thus implicating it in transcription and DNA repair. Al together, the results presented in this thesis make important contributions to better understand the intricate roles played by NuA4 and histone modifications in the repair of DNA to maintain genome integrity.

Tableau d'honneur de la Faculté des études supérieures et postdoctorales, 2005-2006 / La cellule dispose de plusieurs mécanismes de réparation, nécessitant tous l'accès à l'ADN, afin de prévenir les perturbations occasionnées par l'instabilité génomique. La structure des chromosomes eucaryotes (chromatine) forme une barrière physique empêchant l'accessibilité à l'ADN et ainsi les processus biologiques nucléaires tels la transcription, réplication, recombinaison et réparation des dommages de l'ADN. Dans ce dernier processus clé, certaines activités reconfigurant la chromatine pourraient donc s'avérer essentiels en facilitant l'accès à la machinerie de réparation. / Nous avons démontré le recrutement spécifique du complexe histone acétyltransférase NuA4 par immunoprécipitation de chromatine à une cassure double brin de l'ADN, le type de dommage le plus dangereux pour la cellule. Des cinétiques ont permis de déterminer à quel moment NuA4 apparaît au site de cassure en relation avec les modifications de la chromatine environnante et de vérifier l'apparition subséquente de complexes de remodelage ATP dépendant. En parallèle, de nouveaux sites de phosphorylation d'histones qui pourraient être impliqués dans la réparation de dommages sur l'ADN ont été investigués. En conclusion, nos travaux permettent de lier fonctionnellement des complexes de modification/reconfiguration de la chromatine avec le processus de réparation de dommages à l'ADN.

<p>In eukaryotic cells, DNA is packaged into a structure named chromatin which contains DNA and proteins. Nucleosomes are building blocks of chromatin and contain DNA wrapped around a histone octamer. Chromatin modifications (histone post-translational modifications and histone variants) play central roles in various cellular processes including gene expression and DNA damage response. Chromatin modifying enzymes use metabolites as co-substrates and co-factors, and changes in metabolic pathways and metabolite availability affects chromatin modifications and chromatin-associated functions. Moreover, recent studies have uncovered direct roles of metabolic enzymes in chromatin-associated functions. Fumarase, a TCA cycle enzyme that catalyzes the reversible conversion of fumarate to malate in mitochondria (a hydration reaction), is an example of an enzyme with dual functions in metabolism and genome integrity. Cytoplasmic fraction of yeast fumarase, Fum1p, localizes to the nucleus and promotes growth upon DNA damage. Fum1p promotes homologous recombination by enhancing DNA end resection. Human fumarase is involved in DNA repair by non-homologous end joining. Here, we provide evidence that yeast Fum1p and the histone variant Htz1p are also involved in DNA replication stress response and DNA repair by non-homologous end joining (NHEJ). Using mutants lacking the histone variant <i>HTZ1</i>, we show that high cellular levels of fumarate, by deletion of <i>FUM1</i> or addition of exogenous fumarate, suppressed the sensitivity to DNA replication stress by modulation of activity of Jhd2p. This suppression required sensors and mediators of the intra-S phase checkpoint, but not factors involved in the processing of replication intermediates. These results imply that high cellular levels of fumarate can confer resistance to DNA replication stress by bypassing or complementing the defects caused by loss of <i>HTZ1</i> and replication fork processing factors. We also show that upon induction of DSBs, exogenous fumarate conferred resistance to mutants with defects in NHEJ, early steps of homologous recombination (DNA end resection pathway) or late steps of homologous recombination (strand invasion and exchange). Taken together, these results link the metabolic enzyme fumarase and the metabolite fumarate to DNA damage response and show that modulation of DNA damage response by regulating activity of chromatin modifying enzymes is a plausible pathway linking metabolism and nutrient availability to chromatin-associated functions like genome integrity.<br><a></a></p>

The fundamental building blocks of chromatin are the nucleosomes. Each such unit is composed of about 200 bp of DNA, the well-conserved core histones (H2A, H2B, H3 and H4) and a linker histone (H1). The DNA is wound around two dimers of H2A–H2B and a tetramer comprising two molecules each of H3 and H4, and there is approximately one linker histone molecule positioned on the exterior of the DNA–protein octamer complex. The nucleosome directs the various structural transitions in chromatin that are needed for proper transcriptional regulation during differentiation and development of the organism in question. The gene activity can be regulated by different histone variants, DNA–protein interactions, and protein–protein interactions, all of which are influenced by the enormous amounts of post-translational modifications that occur in the histone tails. The research underlying this thesis focused on different aspects of post-translational modifications during aging, differentiation, and progression of the cell cycle, and also on expression of linker histone variants and linker histone-chromatin interactions in a variety of cells and tissues. The present results are the first to show that H4 can be trimethylated at lysine 20 in mammalian cells. The trimethylated H4K20 was found in rat kidney and liver at levels that rose with increasing age of the nimals, and it was also detected in trace amounts in human cell lines. Furthermore, in differentiating MEL cells, trimethylated H4K20 was localized to heterochromatin, and levels of trimethylated H4K20 increased during the course of cell differentiation and were correlated with the increasing compaction of the chromatin. The chromatin of terminally differentiated chicken and frog erythrocytes is highly condensed, and the linker histone variants it contains vary between the two species. Cytofluorometric analyses revealed that the linker histones in the chicken erythrocytes exhibited higher affinity for chromatin than did those in the frog erythrocytes. Characterization of the H1° in frog erythrocytes proved it to be the H1°-2 subvariant. Other experiments demonstrated that normal human B lymphocytes expressed the linker histone variants H1.2, H1.3, H1.4, and H1.5, and that B cells from patients with B-CLL expressed the same variants although in different amounts. The most striking dissimilarity was that amounts of H1.3 in the cells were decreased or undetectable in some samples. Sequencing did not discern any defects in the H1.3 gene, and thus the absence of H1.3 is probably regulated at the post-translational level. It was also observed that the levels of linker histone phosphorylation in EBV-transformed B lymphocytes were already increased in the G1 phase of the cell cycle, which is earlier than previously thought. This increase in phosphorylation is probably responsible for the lower affinity of linker histones for chromatin in EBV-transformed cells in the G1 phase of the cell cycle.

Post translational modifications in histone proteins are transmissible changes that are not coded for in the DNA sequence itself but have a significant affect in the control of gene expression. Eukaryotic transcription is a regulated process, and acetylation plays a major role in this regulation. Deranged equilibrium of histone acetylation can lead to alteration in chromatin structure and transcriptional dysregulation of genes that are involved in the control of proliferation, cell-cycle progression, differentiation and or apoptosis. Evidence shows that high glucose conditions mimicking diabetes can increase histone acetylation and augment the inflammatory gene expression. Recent advances also highlight the involvement of altered histone acetylation in gastrointestinal carcinogenesis or hyperacetylation in amelioration of experimental colitis. However, the role of histone acetylation under obesity conditions is not yet known. Therefore in the present study, western blot analysis in the liver of Zucker obese versus lean rats was performed to determine the pattern and level of H3 and H4 acetylation (both in nuclear and homogenate fractions) at specific lysine (K) in pathological state of hepatic steatosis The same technique was also applied in the liver of obese rats fed higher amounts of vitamin B6 (OH) versus those fed normal amounts of vitamin B6 (ON) to assess if hyper-acetylation can be a protective response to hepatic steatosis. In both experimental models, it was also of interest to elucidate the expression of anti- and pro- apoptotic factor Bcl-2 and Bax in respect to histone acetylation. It was observed that, in liver homogenate fractions in control animals (LC/OC), there was a higher level of histone H3 acetylation at (K9, K14) and H4 acetylation at K5 in the obese animals. In contrast, the nuclear level of H3 and H4 acetylation at the same lysine residues was considerably higher in the lean and lower in the obese animals. Obese animals contained lower liver preneoplastic lesions as well as liver weight as a result of higher amounts of vitamin B6, had significantly higher H3 acetylation at K9 and K14 and H4 acetylation at K5, in both homogenate and nuclear fractions. However, histone acetylation was not detected for histone H4 at lysine 12 (K12) in either control group (LC/OC) or obese with different B6 diet group (OH/ON). Nevertheless, global histone H3 and H4 acetylation in both homogenate and nuclear fractions, was slightly higher in the lean rats and obese rats fed higher amounts of B6. By using the western blot technique, the level of anti- and pro- apoptotic Bcl-2 and Bax were also evaluated. The moderately higher level expression of anti-apoptotic Bcl2 protein was found in lean animals, whereas the expression of pro-apoptotic Bax was significantly higher in obese animals. Furthermore, anti-apoptotic Bcl2 protein expression was slightly higher in the obese rats fed normal amounts of B6 diet; but, pro-apoptotic Bax was higher in the obese rats fed higher amounts of vitamin B6. This is the first study which shows that hyperacetylation of histones in liver nuclei can be correlated with amelioration of hepatic steatotis. Histone acetylation and B6 rich diet might be involved in the regulation of biological availability of key apoptotic proteins, which, in turn, can possibly modify the severity of the disease.

Post translational modifications in histone proteins are transmissible changes that are not coded for in the DNA sequence itself but have a significant affect in the control of gene expression. Eukaryotic transcription is a regulated process, and acetylation plays a major role in this regulation. Deranged equilibrium of histone acetylation can lead to alteration in chromatin structure and transcriptional dysregulation of genes that are involved in the control of proliferation, cell-cycle progression, differentiation and or apoptosis. Evidence shows that high glucose conditions mimicking diabetes can increase histone acetylation and augment the inflammatory gene expression. Recent advances also highlight the involvement of altered histone acetylation in gastrointestinal carcinogenesis or hyperacetylation in amelioration of experimental colitis. However, the role of histone acetylation under obesity conditions is not yet known. Therefore in the present study, western blot analysis in the liver of Zucker obese versus lean rats was performed to determine the pattern and level of H3 and H4 acetylation (both in nuclear and homogenate fractions) at specific lysine (K) in pathological state of hepatic steatosis The same technique was also applied in the liver of obese rats fed higher amounts of vitamin B6 (OH) versus those fed normal amounts of vitamin B6 (ON) to assess if hyper-acetylation can be a protective response to hepatic steatosis. In both experimental models, it was also of interest to elucidate the expression of anti- and pro- apoptotic factor Bcl-2 and Bax in respect to histone acetylation. It was observed that, in liver homogenate fractions in control animals (LC/OC), there was a higher level of histone H3 acetylation at (K9, K14) and H4 acetylation at K5 in the obese animals. In contrast, the nuclear level of H3 and H4 acetylation at the same lysine residues was considerably higher in the lean and lower in the obese animals. Obese animals contained lower liver preneoplastic lesions as well as liver weight as a result of higher amounts of vitamin B6, had significantly higher H3 acetylation at K9 and K14 and H4 acetylation at K5, in both homogenate and nuclear fractions. However, histone acetylation was not detected for histone H4 at lysine 12 (K12) in either control group (LC/OC) or obese with different B6 diet group (OH/ON). Nevertheless, global histone H3 and H4 acetylation in both homogenate and nuclear fractions, was slightly higher in the lean rats and obese rats fed higher amounts of B6. By using the western blot technique, the level of anti- and pro- apoptotic Bcl-2 and Bax were also evaluated. The moderately higher level expression of anti-apoptotic Bcl2 protein was found in lean animals, whereas the expression of pro-apoptotic Bax was significantly higher in obese animals. Furthermore, anti-apoptotic Bcl2 protein expression was slightly higher in the obese rats fed normal amounts of B6 diet; but, pro-apoptotic Bax was higher in the obese rats fed higher amounts of vitamin B6. This is the first study which shows that hyperacetylation of histones in liver nuclei can be correlated with amelioration of hepatic steatotis. Histone acetylation and B6 rich diet might be involved in the regulation of biological availability of key apoptotic proteins, which, in turn, can possibly modify the severity of the disease.

Introdução: O Adenocarcinoma ductal pancreático é um tumor bastante agressivo que apresenta uma alta de letalidade e, para o qual, poucas opções terapêuticas estão disponíveis. Isto pode ser parcialmente explicado pela complexidade derivada de múltiplas aberrações genéticas e da população celular mista presente em um tumor pancreático, o que também pode explicar o curso clínico heterogêneo observado na prática diária. Ultimamente, pesquisas científicas têm contribuído para ampliar o conhecimento sobre o impacto das alterações epigenéticas no desenvolvimento de múltiplos tipos de câncer, porém no pâncreas essas alterações ainda são incertas e, por isso, foco de investigação. A desregulação epigenética parece estar envolvida no ciclo celular da célula tumoral, incluindo o crescimento celular, diferenciação, progressão tumoral e morte celular, e a acetilação das histonas é um importante mecanismo que regula a transcrição de genes envolvidos nesses processos. Padrões globais de modificações das histonas foram recentemente apontados como preditores de desfecho em pacientes com câncer, mas poucos estudos têm sido realizados nesta área, inclusive em Adenocarcinoma ductal pancreático (ADP). Objetivos: O presente estudo foi desenvolvido a fim de investigar o padrão de modificação de acetilação das histonas em adenocarcinoma pancreático, através da análise imunohistoquímica. Materiais e métodos: Uma análise clinicopatológica retrospectiva foi realizada em 119 pacientes diagnosticados com câncer de pâncreas entre os anos de 2005 e 2011, e realizado estudo imunohistoquímico com os anticorpos contra H4K12ac, H3K9ac e H3K18ac. Marcação nuclear positiva para cada histona foi medida quanto à intensidade e expressão, sendo classificadas em grupos de baixa ou de alta intensidade/expressão. Os resultados foram analisados em relação aos parâmetros clinicopatológicos de cada paciente. Resultados: Houve uma relação positiva entre diferenciação tumoral e alta expressão de H4K12ac (P <0,05), bem como a intensidade forte dos três marcadores correlacionou-se positivamente com o estágio do tumor (P <0,01). Análise univariada mostrou pior sobrevida em pacientes com níveis elevados de expressão de H4K12ac (p = 0,038) e H3K18Ac (P = 0,033). Modelo de risco proporcional de Cox revelou o efeito prognóstico independente de níveis elevados de H4K12ac H3K18ac (taxas de risco de 1,6 e 1,7, respectivamente, p <0,05), especialmente para pacientes em estágios iniciais. Sugerimos como hipótese que as modificações na acetilação das histonas H4K12 e H3K18 podem ser consideradas fatores prognósticos importantes para o câncer de pâncreas, embora o mecanismo envolvido necessite de mais investigação. Aumentando a compreensão e o conhecimento sobre o padrão de acetilação das histonas, poder-se-ão finalmente gerar novas idéias para um diagnóstico molecular racional e novas abordagens terapêuticas. / Introduction: Ductal pancreatic adenocarcinoma (DPAs) is a highly aggressive tumor, with a high letality rate, for which few therapeutic options are available. This may be partially explained by the notorious complexity derived from the multiple genetic aberrations and mixed cellular population present in a pancreatic tumor, which can also explain the heterogeneous clinical course observed in daily practice. Lately, there is an increase in the literature about the impact of epigenetic changes on the development of several cancer, however in the pancreas these changes are still uncertain. Epigenetic deregulation may be involved in tumor cell biology, including cell growth, differentiation, tumor progression and cell death, and histone acetylation is a major mechanism that regulates gene transcription. Patterns of global histone modifications have been recently suggested as outcome predictors in cancer patients, but few studies have been conducted on pancreatic ductal adenocarcinomas. Objectives: This study was designed to investigate the predictive value of histone acetylation modifications on pancreatic cancer. Material and methods: A retrospective clinicopathologic analysis was undertaken in 119 patients diagnosed with PDAC between 2005 and 2011, and immunohistochemistry performed with antibodies against H4K12ac, H3K9ac and H3K18ac. Positive nuclear staining for each histone was measured as the intensity and expression, being classified into low or high-staining groups. Results were analyzed in relation to patients’ clinicopathologic parameters. Results: There was a positive relationship between tumor differentiation and H4K12ac high scores (P<0.05) and staining of the three markers correlated positively with tumor stage (P<0.01). Univariate analysis showed worse survival in patients with high detection levels of H4K12ac (p=0.038) and H3K18Ac (P=0.033). A backwards Cox proportional hazards model revealed the independent prognostic effect of high H4K12ac and H3K18ac levels (hazard ratios of 1.6 and 1.7 respectively, p<0.05), especially for patients at early stages. We hypothesize that acetylation of H4K12 and H3K18 may be considered valuable prognostic factors for pancreatic cancer, although the mechanism involved needs further investigation. Increasing insights into histone acetylation modifications can ultimately generate new ideas for rationally and molecularly based diagnostic and therapeutic approaches.

Introdução: O Adenocarcinoma ductal pancreático é um tumor bastante agressivo que apresenta uma alta de letalidade e, para o qual, poucas opções terapêuticas estão disponíveis. Isto pode ser parcialmente explicado pela complexidade derivada de múltiplas aberrações genéticas e da população celular mista presente em um tumor pancreático, o que também pode explicar o curso clínico heterogêneo observado na prática diária. Ultimamente, pesquisas científicas têm contribuído para ampliar o conhecimento sobre o impacto das alterações epigenéticas no desenvolvimento de múltiplos tipos de câncer, porém no pâncreas essas alterações ainda são incertas e, por isso, foco de investigação. A desregulação epigenética parece estar envolvida no ciclo celular da célula tumoral, incluindo o crescimento celular, diferenciação, progressão tumoral e morte celular, e a acetilação das histonas é um importante mecanismo que regula a transcrição de genes envolvidos nesses processos. Padrões globais de modificações das histonas foram recentemente apontados como preditores de desfecho em pacientes com câncer, mas poucos estudos têm sido realizados nesta área, inclusive em Adenocarcinoma ductal pancreático (ADP). Objetivos: O presente estudo foi desenvolvido a fim de investigar o padrão de modificação de acetilação das histonas em adenocarcinoma pancreático, através da análise imunohistoquímica. Materiais e métodos: Uma análise clinicopatológica retrospectiva foi realizada em 119 pacientes diagnosticados com câncer de pâncreas entre os anos de 2005 e 2011, e realizado estudo imunohistoquímico com os anticorpos contra H4K12ac, H3K9ac e H3K18ac. Marcação nuclear positiva para cada histona foi medida quanto à intensidade e expressão, sendo classificadas em grupos de baixa ou de alta intensidade/expressão. Os resultados foram analisados em relação aos parâmetros clinicopatológicos de cada paciente. Resultados: Houve uma relação positiva entre diferenciação tumoral e alta expressão de H4K12ac (P <0,05), bem como a intensidade forte dos três marcadores correlacionou-se positivamente com o estágio do tumor (P <0,01). Análise univariada mostrou pior sobrevida em pacientes com níveis elevados de expressão de H4K12ac (p = 0,038) e H3K18Ac (P = 0,033). Modelo de risco proporcional de Cox revelou o efeito prognóstico independente de níveis elevados de H4K12ac H3K18ac (taxas de risco de 1,6 e 1,7, respectivamente, p <0,05), especialmente para pacientes em estágios iniciais. Sugerimos como hipótese que as modificações na acetilação das histonas H4K12 e H3K18 podem ser consideradas fatores prognósticos importantes para o câncer de pâncreas, embora o mecanismo envolvido necessite de mais investigação. Aumentando a compreensão e o conhecimento sobre o padrão de acetilação das histonas, poder-se-ão finalmente gerar novas idéias para um diagnóstico molecular racional e novas abordagens terapêuticas. / Introduction: Ductal pancreatic adenocarcinoma (DPAs) is a highly aggressive tumor, with a high letality rate, for which few therapeutic options are available. This may be partially explained by the notorious complexity derived from the multiple genetic aberrations and mixed cellular population present in a pancreatic tumor, which can also explain the heterogeneous clinical course observed in daily practice. Lately, there is an increase in the literature about the impact of epigenetic changes on the development of several cancer, however in the pancreas these changes are still uncertain. Epigenetic deregulation may be involved in tumor cell biology, including cell growth, differentiation, tumor progression and cell death, and histone acetylation is a major mechanism that regulates gene transcription. Patterns of global histone modifications have been recently suggested as outcome predictors in cancer patients, but few studies have been conducted on pancreatic ductal adenocarcinomas. Objectives: This study was designed to investigate the predictive value of histone acetylation modifications on pancreatic cancer. Material and methods: A retrospective clinicopathologic analysis was undertaken in 119 patients diagnosed with PDAC between 2005 and 2011, and immunohistochemistry performed with antibodies against H4K12ac, H3K9ac and H3K18ac. Positive nuclear staining for each histone was measured as the intensity and expression, being classified into low or high-staining groups. Results were analyzed in relation to patients’ clinicopathologic parameters. Results: There was a positive relationship between tumor differentiation and H4K12ac high scores (P<0.05) and staining of the three markers correlated positively with tumor stage (P<0.01). Univariate analysis showed worse survival in patients with high detection levels of H4K12ac (p=0.038) and H3K18Ac (P=0.033). A backwards Cox proportional hazards model revealed the independent prognostic effect of high H4K12ac and H3K18ac levels (hazard ratios of 1.6 and 1.7 respectively, p<0.05), especially for patients at early stages. We hypothesize that acetylation of H4K12 and H3K18 may be considered valuable prognostic factors for pancreatic cancer, although the mechanism involved needs further investigation. Increasing insights into histone acetylation modifications can ultimately generate new ideas for rationally and molecularly based diagnostic and therapeutic approaches.